New Jersey Cancer Care Joins Regional Cancer Care Associates
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and best possible outcomes.
A reputation for excellence requires commitment to dedication, long hours, compassion and the motivation to excel. These attributes are an apt description of Regional Cancer Care Associates, with doctors who are routinely recognized as among the best in their field.
This year, six RCCA physicians were recognized as Top Doctors for Women’s Health specializing in oncology as selected by health care research and information company Castle Connolly. Through its independent, exhaustive method of peer nomination, research, review and screening, Castle Connolly has a reputation as America’s trusted source for identifying top physicians.
RCCA’s doctors guide patients through their medical journey with skill, compassion, leadership and collaboration. Leading their field to new heights of effective care and working closely with fellow clinical team members to provide the best care possible, they represent excellence in their medical specialty. Their skill and patient-centered focus are distinguished as the best of the best.
The six RCCA physicians named to Castle Connolly’s 2023 list of Top Doctors for Women’s Health in New Jersey are:
May Abdo-Matkiwsky, DO, serving the Sparta community
Maurice Cairoli, MD, serving the Moorestown community
Denis Fitzgerald, MD, serving the Little Silver community
Anthony Ingenito, MD, serving the Hackensack community
Mark Pascal, MD, serving the Franklin Lakes/Hackensack community
Stanley Waintraub, MD, serving the Hackensack community
Only 7% of the more than 850,000 practicing physicians in the U.S. are named to the Top Doctors list. The designation is made only after a rigorous vetting process conducted by an experienced medical review board. Each doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients, are taken into consideration.
RCCA has 90-plus cancer specialists who treat patients at more than 20 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 26,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians. They offer patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma and rheumatoid arthritis — who take intravenously-administered medications.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and best possible outcomes.
Commitment, dedication and passion are attributes that show through in every aspect of care at Regional Cancer Care Associates.
Recent research has caused many healthcare professionals to reconsider their approach to screening men for prostate cancer. That’s because the disease (already the second most
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.